Locate St. Petersburg buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Dr. Michael Lloyd Whitworth, M.D.
West Florida Pain Management
603 7th Street South, Suite 320
St. Petersburg, FL 33701
Main Tel: (727) 553-7313
|
|
Dr. Bruce Charles Welch, M.D.
535 Central Avenue
Saint Petersburg, FL 33701
Main Tel: (727) 823-2253
|
|
Dr. Danya Alida Godoy,
620 10th Street North
Saint Petersburg, FL 33705
Main Tel: (727) 824-8383
|
|
Dr. Alina Gonzalez-Mayo, M.D.
1201 5th Avenue North
Suite 305
St. Petersburg, FL 33705
Main Tel: (727) 327-3737
|
|
|
|
Dr. Mehul Shah, M.D.
1111 7th Avenue North
Suite 107
Saint Petersburg, FL 33705
Main Tel: (727) 894-1661
|
|
Dr. James Razi, M.D.
1111 7th Avenue North
Suite 107
Saint Petersburg, FL 33705
Main Tel: (727) 360-1663
|
|
Ricky Poole Lockett, M.D.
1501 Fifth Avenue North
St. Petersburg, FL 33705
Main Tel: (727) 896-8686
|
|
Dr. David Cheesman, D.O.
2121 5th Avenue N.
Saint petersburg, FL 33713
Main Tel: (407) 629-0413
|
|
Dr. David Cheesman, D.O.
2121 5th Ave N.
Saint petersburg, FL 33713
Main Tel: (727) 239-7246
|
|
Dr. Awais Asghar Siddiki, M.D.
Clear Path Center PA
3177 4th Street North
St Petersburg, FL 33704
Main Tel: (877) 585-2955
|
|
Dr. Vinod Singh, M.D.
3177 4th Street North
St. Peterburg, FL 33704
Main Tel: (877) 585-2955
|
|
Dr. Akif Ahmad, M.D.
Clear Path Center PA
3177 4th Street North
Saint Petersburg, FL 33704
Main Tel: (877) 585-2955
|
|
Dr. Vinod Singh, M.D.
3177 4th ST. N
St. Petersburg, FL 33704
Main Tel: (877) 585-2955
|
|
Dr. Ed W. Jackson, M.D.
Suncaost Community Mental Health
4010 Central Avenue
St. Petersburg, FL 33711
Main Tel: (727) 327-7656
|
|
Antoinette M. Falk, M.D.
941 Live Oak Avenue, NE
St. Petersburg, FL 33703
Main Tel: (727) 526-6699
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for